This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Geojit Research Keeps Their Hold Rating on Dr. Reddy’s Laboratories Ltd. (DRREDDY)
Geojit Research analyst maintained a Hold rating on Dr. Reddy’s Laboratories Ltd. yesterday and set a price target of INR1,390.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dr. Reddy’s Laboratories Ltd. has an analyst consensus of Moderate Buy, with a price target consensus of INR1,413.33.
Read More on IN:DRREDDY:
Disclaimer & DisclosureReport an Issue
- Dr. Reddy’s reports FDA acceptance to review Abatacept BLA
- Coya Therapeutics to sell 2.522M shares at $4.40 in private placement
- Dr. Reddy’s Posts Q3 FY26 Earnings Call Transcript for Investors
- Dr. Reddy’s Publishes Audio Recording of Q3 FY2026 Earnings Call
- Dr. Reddy’s Releases Q3 FY26 Unaudited Results Investor Presentation
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
